 So the researchers for this group concluded that Prevagen could improve aspects of cognitive function in people with normal brain-related aging or very mild cognitive impairment. That was the result. So some neuroscientists had a different take on the results. They said the study didn't show that people who took Prevagen significantly benefited more than the placebo group. So that's really what it comes down to. You can interpret these facts any way you want. The one interpretation would be, well, there's nothing significant about this. You did this study and there was very little benefit.